Predicted to enable alditol:NADP+ 1-oxidoreductase activity. Predicted to be involved in prostaglandin metabolic process. Predicted to be active in cytosol and mitochondrion. Orthologous to human AKR1B10 (aldo-keto reductase family 1 member B10) and AKR1B15 (aldo-keto reductase family 1 member B15). [provided by Alliance of Genome Resources, Apr 2022]